Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „expected“
Suchtreffer
Begriffe & Kennungen
Exforge HCT · 4.8 · In the 8-week controlled clinical study, no significant new or unexpected adverse reactions were observed with
Eintrag öffnenEylea · 4.8 · The following adverse reactions of Eylea 40 mg/ml are also considered expected with Eylea 114.3 mg/ml: abnorma
Eintrag öffnenFabrazyme · 4.8 · Since agalsidase beta (r-hαGAL) is a recombinant protein, the development of IgG antibodies is expected in pat
Eintrag öffnenFamiliencharakteristika
Eintrag öffnenFebuxostat Viatris (previously Febuxostat Mylan) · 4.5 · Thus, co-administration of febuxostat with other CYP2D6 substrates is not expected to require any dose adjustm
Eintrag öffnenFendrix · 4.5 · It may be expected that in patients receiving immunosuppressive treatment or patients with immunodeficiency, a
Eintrag öffnenFirazyr · 4.5 · Pharmacokinetic drug interactions involving CYP450 are not expected (see section 5.2).
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.5 · It is expected that the same interactions than those mentioned for the adults may be presented by the paediatr
Eintrag öffnenFlebogamma DIF (previously Flebogammadif) · 4.5 · It is expected that the same interactions than those mentioned for the adults may be presented by the paediatr
Eintrag öffnenFuzeon · 4.5 · No clinically significant pharmacokinetic interactions are expected between enfuvirtide and concomitantly give
Eintrag öffnenFycompa · 4.5 · Strong inducers of cytochrome P450, such as rifampicin and hypericum, are expected to decrease perampanel conc
Eintrag öffnenFycompa · 4.5 · Strong inducers of cytochrome P450, such as rifampicin and hypericum, are expected to decrease perampanel conc
Eintrag öffnenGenvoya · 4.5 · Based on non-CYP-mediated elimination pathways for lorazepam, no effect on plasma concentrations is expected u
Eintrag öffnenGenvoya · 4.5 · Co-administration of clopidogrel with cobicistat is expected to decrease clopidogrel active metabolite plasma
Eintrag öffnenGenvoya · 4.5 · Genvoya is not expected to have a clinically relevant effect on plasma concentrations of the active metabolite
Eintrag öffnenHalaven · 4.5 · No drug-drug interactions are expected with CYP3A4 inhibitors and inducers. Eribulin exposure (AUC and Cmax) w
Eintrag öffnenHarvoni · 4.5 · (Induction of P-gp) Rifabutin Interaction not studied. Harvoni is contraindicated with rifabutin (see Expected
Eintrag öffnenHarvoni · 4.5 · (Induction of P-gp) Rifabutin Interaction not studied. Harvoni is contraindicated with rifabutin (see Expected
Eintrag öffnenHarvoni · 4.5 · (Induction of P-gp) Rifampicin (600 mg once Interaction not studied. daily)/ sofosbuvir (400 mg Expected: sing
Eintrag öffnenHarvoni · 4.5 · Expected: ↔ Sofosbuvir ↔ GS-331007
Eintrag öffnen